Aquestive Therapeutics (AQST) Receivables (2017 - 2026)
Aquestive Therapeutics' Receivables was $9.33 million in Q2 2026, down 33.7% from $14.07 million a year earlier but up 35.8% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Aquestive Therapeutics came in at $17.76 million, up 80.9% from FY2024.
- Receivables shows a five-year compound annual growth rate of 20.6% (FY2020 to FY2025).
- In earlier years, Receivables was $9.82 million in FY2024 (-13.8%), $11.39 million in FY2023 (+142.0%), $4.7 million in FY2022 (-61.2%) and $12.12 million in FY2021 (+74.3%).
- Quarterly Receivables has moved between $4.7 million (Q4 2022) and $19.9 million (Q1 2022) over five years.
- Compared with a year earlier, Receivables was higher in five of the last eight quarters, with growth averaging 19.5%.
- The best year-over-year quarter for Receivables over five years was Q4 2023 (growth of 142.0%); the worst was Q1 2023 (a decline of 62.0%).
- Per Business Quant data, AQST's Receivables in the three quarters before Q2 2026 was $6.87 million (Q1 2026), $17.76 million (Q4 2025) and $14.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Aquestive Therapeutics | 596.18 Mn | 136.72 Mn | 9.80 Mn | 9.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.33 Mn |
| Mar 31, 2026 | 6.87 Mn |
| Dec 31, 2025 | 17.76 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Jun 30, 2025 | 14.07 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 9.82 Mn |
| Sep 30, 2024 | 11.68 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | 11.39 Mn |
| Sep 30, 2023 | 8.55 Mn |
| Jun 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 7.55 Mn |
| Dec 31, 2022 | 4.70 Mn |
| Sep 30, 2022 | 10.74 Mn |
| Jun 30, 2022 | 19.17 Mn |
| Mar 31, 2022 | 19.90 Mn |
| Dec 31, 2021 | 12.12 Mn |
| Sep 30, 2021 | 13.64 Mn |
API Access
Aquestive Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();